Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.330
+0.010 (0.43%)
At close: Apr 28, 2026, 4:00 PM EDT
2.370
+0.040 (1.72%)
After-hours: Apr 28, 2026, 5:31 PM EDT
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $10.23 million as of April 28, 2026. Its market cap has increased by 31.11% in one year.
Market Cap
10.23M
Enterprise Value
-6.32M
1-Year Change
31.11%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $10.23M, a decrease of -73.71%. That is a compound annual growth rate of -11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.20M | 27.78% |
| Dec 31, 2025 | 7.20M | -27.27% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 11.19M |
| Chemomab Therapeutics | 11.09M |
| Cellectar Biosciences | 11.07M |
| Imunon | 10.98M |
| BioLineRx | 10.52M |
| Enveric Biosciences | 10.13M |
| Aprea Therapeutics | 9.86M |
| Quoin Pharmaceuticals | 9.85M |